Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Ann Fr Anesth Reanim ; 31(10): 778-82, 2012 Oct.
Artigo em Francês | MEDLINE | ID: mdl-22795773

RESUMO

OBJECTIVE: Since the last consensus conducted by Sfar/SRLF, the use of protocol for sedation became the reference in our ICUs. Decrease in length of stay and length of mechanical ventilation with used of these protocols have been already described. We would like to investigate the economic impact associated. STUDY DESIGN: Using the PMSI data, we studied retrospectively, the economic effect, one year before and one year after protocol implementation in our ICU. METHOD: The economic evaluation compared the cost of sedation but also the cost of mechanical ventilation and length of stay in ICU. RESULTS: Characteristic and number of patients were equivalent during the two years. We described a significant decrease in length of mechanical ventilation (8.8 vs. 8.4; p<0.05) but not in length of stay (11.4 vs. 11.7; NS) between the two periods. We described a decrease of sedation cost of 11 412 euros and a decrease of mechanical ventilation cost of 27 360 Euros between the two years. CONCLUSION: We confirm in this study that use of sedation protocol in ICU is associated with a clinical impact but also with an economic effect.


Assuntos
Sedação Consciente/economia , Cuidados Críticos/economia , Adulto , Idoso , Protocolos Clínicos , Sedação Consciente/métodos , Sedação Consciente/estatística & dados numéricos , Custos e Análise de Custo , Cuidados Críticos/métodos , Bases de Dados Factuais , Feminino , Fentanila/economia , Fentanila/uso terapêutico , França , Humanos , Hipnóticos e Sedativos/economia , Hipnóticos e Sedativos/uso terapêutico , Unidades de Terapia Intensiva , Tempo de Internação , Pneumopatias/etiologia , Pneumopatias/prevenção & controle , Masculino , Midazolam/economia , Midazolam/uso terapêutico , Pessoa de Meia-Idade , Piperidinas/economia , Piperidinas/uso terapêutico , Remifentanil , Respiração Artificial/economia , Respiração Artificial/métodos , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA